5Wells GA, Cranney A, PetersonJ, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women [CDJ . Cochrane Datebase Syst Rev[J] . 2008, 23: CD003376.
6Chesnut CH, McClung MR, Ensrud KE, et al. Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling[J]. AmJ Med, 1995,99:144-152.
7DevogelaerJP,Broll H,Correa-Rotter R, et al. Oral alendronate induces progressive increases in bone mass of the spine, hip. and total body over 3 years in postmenopausal women with osteoporosis[J] . Bone, 1996,18:141-150.
8Bone HG, Downs RW, TucciJR, et al. Dose?response relationships for alendronate treatment in osteoporotic elderly women[J].J Clin Endocrinol Metab, 1997,82: 265-274.
9Hosking D. Chilvers CE, christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age[J]. N EnglJ Med,1998,338: 485-492.
10McClung M. Clemmesen B. Daifotis A, et al. Alendronate prevents postmenopausal bone loss in women without osteoporosis - A double-blind. randomized, controlled trial[J] . Annals of Internal Medicine, 1998,128: 253-261.
